TNFRSF10B and hepatitis B virus infection: It would be interesting to see whether histological assessment of the balance of expression of death-inducing TRAIL-R2 versus inhibitory TRAIL-R3/4 on hHSC in biopsy tissue from patients with hepatitis B or other liver diseases can serve as a personalised predictor of fibrosis progression.